Inovio Pharmaceuticals, Inc. · NASDAQ:INO

The Vanguard Group reported a 5.53% stake in Inovio Pharmaceuticals, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed Apr 30, 2025

The Vanguard Group reported a 5.53% stake in Inovio Pharmaceuticals, Inc., 2,028,959 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G).

Stake
5.53%
Shares
2,028,959
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
The Vanguard Group5.53%2,028,959

Source

View original at SEC

Related